Thanks to the extraordinary conviction of our supporters, we surpassed $1.6M in commitments for the event. Seeing our partners, families, and industry leaders unite behind this mission is a true testament to Dan’s legacy and our shared commitment to transforming the glioblastoma landscape.

The invitational also showcased how our venture philanthropy model moves from bench to bedside. We were honored to host guest speakers:

Dr. Raphael Besborodco (Zyntha) — on next-generation clinical tools and diagnostics.

Dr. Chetan Bettegowda (Johns Hopkins) — on breakthrough research bypassing historical bottlenecks.

Dr. Eddie Martucci (Alterris Oncology) — on early-stage biotech spinouts and therapeutic platforms.

Dr. Jessica D. Schulte (NYU Langone) — on the critical care networks and patient-centric programs we are scaling.